SCHEMBL1037993

SCHEMBL1037993

O=C(CBr)N1CCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21765685 0.97 ALDH1A1 (0.54)
SCHEMBL772021 0.97 ATM (0.54)
SCHEMBL20129907 0.94
SCHEMBL21765684 0.94 ALDH1A1 (0.50)
SCHEMBL27155224 0.88 ALDH1A1 (0.62)
SCHEMBL8149192 0.88 ALDH1A1 (0.62)
SCHEMBL2110436 0.79 ALDH1A1 (0.52)
SCHEMBL20985713 0.79 ALDH1A1 (0.81)
SCHEMBL11761315 0.79 ATM (0.46)
SCHEMBL21765680 0.78 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 171 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129077-A1 SUBSTITUTED PURINES AS TLR7 AGONISTS Primmune Therapeutics, Inc. 2025-04-24 US disclosed
EP-4512816-A2 TLR7 AGONISTS Primmune Therapeutics, Inc. (US) 2025-02-26 EP disclosed
CN-112533607-B TLR7 agonists 普利缪尼治疗学股份有限公司 2025-01-07 CN disclosed
CN-114423775-B Aryl glucoside derivative, and preparation method and application thereof 上海喆邺生物科技有限公司 2024-11-22 CN disclosed
US-20240376099-A1 COMPOUNDS AND COMPOSITIONS AS INHIBITORS OF ENDOSOMAL TOLL-LIKE RECEPTORS NOVARTIS AG (CH) 2024-11-14 US disclosed
EP-3801538-B1 TLR7 AGONISTS PRIMMUNE THERAPEUTICS INC (US) 2024-10-02 EP disclosed
WO-2024153595-A1 CHROMANE DERIVATIVES AS EGFR SELECTIVE INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2024-07-25 WO disclosed
US-12037335-B2 Substituted purines as TLR7 agonists Primmune Therapeutics, Inc. (US) 2024-07-16 US disclosed
WO-2024084447-A2 AZETIDINYL BENZOXAZOLE COMPOUNDS AND THEIR USE AS MER AND AXL INHIBITORS DONG-A ST CO., LTD. (KR) 2024-04-25 WO disclosed
CN-117597329-A Method for the catalytic synthesis of tryptamine and precursors thereof 凯尔化学科技公司 2024-02-23 CN disclosed
WO-1993008175-A1 BENZODIAZEPINE DERIVATIVES AS ANTAGONISTS OF GASTRIN AND/OR CHOLECYSTOKININ GLAXO GROUP LIMITED (GB) 1993-04-29 WO disclosed
EP-0538945-A1 Benzodiazepine derivatives, and their use as antagonists of gastrin and/or cholecystokinin GLAXO GROUP LIMITED (GB) 1993-04-28 EP disclosed
US-5071869-A 2-FLUOROCYCLOPROPYLACETIC ACID ESTERS, PROCESSES FOR THEIR PREPARATION AND THEIR USE AS PESTICIDES SCHERING AKTIENGESELLSCHAFT (DE) 1991-12-10 US disclosed
US-5037976-A Antimicrobial Agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1991-08-06 US disclosed
EP-0432861-A1 Halogenated olefines, process for the preparation thereof and their use as pesticides SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-19 EP disclosed
EP-0430380-A2 2-Fluorocyclopropylacetic acid esters, processes for their preparation and their use as pesticides SCHERING AKTIENGESELLSCHAFT (DE) 1991-06-05 EP disclosed
US-5019573-A Substituted dibenzofurans and methods of using same EUROCELTIQUE, S.A. (LU) 1991-05-28 US disclosed
EP-0422329-A1 Substituted dibenzofurans and methods of using same Euro-Celtique S.A. (LU) 1991-04-17 EP disclosed
US-4898859-A 2-Oxa-isocephem compounds and compositions containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1990-02-06 US disclosed
EP-0282895-A2 2-oxa-isocephem compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-09-21 EP disclosed